Medicine goes to school: Teachers as sickness brokers for ADHD

PLoS Medicine

Volumn 3, Issue 4, 2006, Pages 433-435

  Phillips, Christine B ^a  

^a The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; CONSUMER HEALTH INFORMATION; COST BENEFIT ANALYSIS; DISRUPTIVE BEHAVIOR; DRUG INDUSTRY; DRUG INFORMATION; DRUG USE; DYSLEXIA; HEALTH PROGRAM; HUMAN; INFORMATION CENTER; INFORMATION RETRIEVAL; INFORMATION SERVICE; MEDICAL ASSESSMENT; PATIENT COUNSELING; PRESCRIPTION; RATING SCALE; SHORT SURVEY; SUPPORT GROUP; TEACHER; ADVERTIZING; ARTICLE; CHILD; EDUCATIONAL STATUS; INTERNET; OUTCOME ASSESSMENT; PATIENT ADVOCACY; POLITICS; UNIVERSITY;

ADVERTISING AS TOPIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DRUG INDUSTRY; EDUCATIONAL STATUS; FACULTY; HUMANS; INFORMATION SERVICES; INTERNET; LOBBYING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADVOCACY;

EID: 33646270615     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030182     Document Type: Short Survey

References (28)

1. Safer DJ, Zito JM, Fine EM (1996) Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98: 1084-1088.
2. Miller A, Lee SK, Raina P, Klassen A, Zupanic J, et al. (1998) A review of therapies for attention-deficit/hyperactivity disorder. Ottawa: Canadian Coordinating Office for Health Technology Assessment. Available: http://www.ccohta.ca/newweb/pubapp/pdf/adhd_tech_rep.pdf. Accessed 29 January 2006.
3. Salmelainen P (2002) Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales. N S W Public Health Bull 13 (Supplement S-1): 1-65.
4. Breggin PR (2002) The Ritalin fact book: What your doctor won't tell you about ADHD and stimulant drugs. Cambridge (Massachusetts): Perseus Publishing. 208 p.
5. Church of Scientology International (2006) Protecting the rights of children. Available: http://www.scientology-europe.org/en_US/pub/human-rights/pg011.html. Accessed 29 January 2006.
6. American Academy of Pediatrics (2006) Children's health topics: ADHD. Available: http://www.aap.org/healthtopics/adhd.cfm. Accessed 29 January 2006.
7. Conrad P (1992) Medicalization and social control. Ann Rev Sociol 18: 209-232.
8. Conners CK (1997) Manual for the Conners' Rating Scales - Revised. North Tonawanda (New York): Multi-Health Systems.
9. Sax L, Kautz KJ (2003) Who first suggests the diagnosis of attention-deficit/hyperactivity disorder? Ann Fam Med 1: 171-174.
10. Malacrida C (2004) Medicalization, ambivalence and social control: Mothers' descriptions of educators and ADD/ADHD. Health 8: 61-80.
11. Shire Pharmaceutical Group (2005) ADHD support. Available: http://www.adhdsupportcompany.com. Accessed 23 December 2005.
12. Novartis Pharmaceuticals Corporation (2005) If parents ask... Available: http://www.adhdinfo.com/info/school/caring/sch_if_parents_ask.jsp. Accessed 19 December 2005.
13. Novartis Pharmaceuticals Corporation (2006) Novartis Pharmaceuticals USA. Available: http://www.pharma.us.novartis.com/index.jsp?TNav. Accessed 14 February 2006.
14. Shire Pharmaceutical Group (2006) Adderell XR. Available: http://www.adderallxr.com. Accessed 14 September 2005.
15. Shire Pharmaceutical Group (2005) Celebrity carpenter Ty Pennington to host ADHD experts on call program [press release]. Available: http://psychcentral.com/news/archives/2005-09/pn-net091405.html. Accessed 14 February 2006.
16. Kidsonline (2006) National Association of School Nurses (NASN) supports educational program about management of attention deficit hyperactivity disorder (ADHD) in schools. Available: http://www.kidsource.com/kidsource/content3/news3/adhd.nurses.html. Accessed 29 January 2006.
17. Novartis Pharmaceuticals Corporation (2002) Straight talk about responsible treatment (START). Available: http://www.adhdinfo.com/startnow/index.jsp. Accessed 29 January 2006.
18. CHADD (2005) CHADD Annual Report 2004-2005. Available: http://www.chadd.org/pdfs/2005_Annual_Report.pdf. Accessed 2005.
19. CHADD (2004) Reaching educators. Available: http://www.chadd.org/webpage.cfm?cat_id=10&subcat_id=77. Accessed 23 December 2005.
20. Foggo D (2005) ADHD advice secretly paid for by drugs companies. Available: http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2005/10/09/nadhd09.xml. Accessed 29 January 2006.
21. GlaxoSmithKline (2004) Partners with education. Available: http://www.gsk.com/education/index.htm. Accessed 23 December 2005.
22. Pfizer (2004) Pfizer Learning Lab. Available: http://www.pfizerlearninglab.co.uk/hp.aspx. Accessed 23 December 2005.
23. Association of the British Pharmaceutical Industry (2005) Resources for schools. Available: http://www.abpischools.org.uk. Accessed 23 December 2005.
24. Story M, French S (2004) Food Advertising and marketing directed and children and adolescents in the US. Int J Behav Nutr Phys Act 10: 3.
25. Linn SE (2004) Food marketing to children in the context of a marketing maelstrom. J Public Health Pol 25: 367-378.
26. Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN (2004) The ethics of pharmaceutical industry relationships with medical students. Med J Australia 180: 411-414.
27. Wilkes MS, Hoffman JR (2001) An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 76: 1271-1277.
28. Mansfield PR (1997) MaLAM, a medical lobby for appropriate marketing of pharmaceuticals. Med J Australia 167: 590-592.